IR Engineer Education Institute will hold a seminar on legal and regulatory compliance for healthcare advertising. Centered on Japan’s Act against Unjustifiable Premiums and Misleading Representations, the seminar will provide a cross-sectional overview of key points under the Pharmaceuticals and Medical Devices Act, Health Promotion Act, Medical Care Act, and related guidelines. Participants will learn how to develop advertising plans, supporting evidence, and review processes that are less likely to be challenged by regulators, based on enforcement cases and administrative perspectives. Healthcare advertising directly concerns consumers’ bodies, health, and beauty, making it an area subject to stricter regulation and closer social scrutiny than ordinary consumer goods. In addition to rules under the Premiums and Representations Act, such as misleading superiority claims and misleading advantage claims, healthcare advertising is also affected by the Pharmaceuticals and Medical Devices Act, Health Promotion Act, Medical Care Act, and various guidelines. Proceeding with planning, production, and review without a clear overview of which law applies in which situation can lead to risks such as administrative sanctions, improvement guidance, injunctions, and public backlash. In recent years, a broader range of customer touchpoints has increasingly come under scrutiny, including landing pages, social media, reviews, testimonials, before-and-after content, No. 1 claims, and affiliate marketing initiatives. Seminar title: Practical Seminar on Legal and Regulatory Compliance for Healthcare Advertising Format: In-person attendance only; no online streaming Date and time: Wednesday, June 10, 2026, 13:00 to 15:30 Venue: Japan IR Co., Ltd. head office seminar room Capacity: 16 participants Fee: JPY 19,800 per person, tax included; group discounts available Lecturer: Tomohiro Matsushita, attorney at Unvis Law Office The seminar will first organize the overall framework of health